The Tech Billionaires Funding A.I.’s Next Chapter on Campus
Jensen Huang and his wife, Lori Huang, attend the 12th Breakthrough Prize Ceremony at Barker Hangar in Santa…
SpaceX and other mega AI deals are lifting big bank profits. CEOs say more are coming.
Wall Street’s biggest banks are taking a victory lap this week after a global AI boom fueled one…
US stocks rise as Wall Street shows it’s still hungry for AI winners
NEW YORK (AP) — U.S. stocks ticked higher Friday after Wall Street showed its appetite is still big…
US factory production flat in May as AI investment supports manufacturing
WASHINGTON (Reuters) – U.S. factory production was unexpectedly unchanged in May after gains in the prior months, which…
OpenAI IPO: Sam Altman Reportedly Reveals Timeline, Hints At Major AI Upgrade
The ChatGPT maker has reportedly outlined a potential IPO timeline and is preparing to launch a new AI…
Fresh off bond sale, Amazon borrows $17.5B from banks as AI spending continues
Companies are burning through exorbitant sums of money to keep pace in the AI arms race. Debt is…
Hong Kong stocks struggle as mainland China markets ride AI wave
Signs are omnipresent that mainland Chinese investors are rotating out of Hong Kong stocks and back to the…
Citi, JPM Reportedly In Talks To Join OpenAI IPO Bank Lineup
A confidential IPO filing is reportedly expected soon, with the listing set to be one of the most…
Citi, JPM Reportedly In Talks To Join OpenAI IPO Bank Lineup
The two banks could reportedly join Goldman Sachs and Morgan Stanley, though no final decision has been made.…
Anthropic’s Mythos sends US banks rushing to plug cyber holes
US banks are rushing to fix scores of IT system weaknesses flagged by Anthropic‘s powerful but costly Mythos…
Citigroup lifts AI market view to over $4 trillion on enterprise adoption
April 28 (Reuters) – Citigroup raised its global artificial intelligence market forecast, citing faster-than-expected enterprise adoption of artificial…
As China’s biotech firms shift gears, can AI floor the accelerator?
A quarter featuring multiple eye-popping deals is no longer unusual for China’s pharmaceutical industry – in fact, it…